These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 34294773)
21. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299 [TBL] [Abstract][Full Text] [Related]
22. Autophagy-related gene Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756 [TBL] [Abstract][Full Text] [Related]
23. Runx1 and Runx3 drive progenitor to T-lineage transcriptome conversion in mouse T cell commitment via dynamic genomic site switching. Shin B; Hosokawa H; Romero-Wolf M; Zhou W; Masuhara K; Tobin VR; Levanon D; Groner Y; Rothenberg EV Proc Natl Acad Sci U S A; 2021 Jan; 118(4):. PubMed ID: 33479171 [TBL] [Abstract][Full Text] [Related]
24. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap. Shi B; Ding J; Qi J; Gu Z Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477 [TBL] [Abstract][Full Text] [Related]
25. Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma. Wu Y; Xu Z; Chen X; Fu G; Tian J; Shi Y; Sun J; Jin B Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109674 [No Abstract] [Full Text] [Related]
26. Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681 [TBL] [Abstract][Full Text] [Related]
27. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells. Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375 [TBL] [Abstract][Full Text] [Related]
28. HOXD1 functions as a novel tumor suppressor in kidney renal clear cell carcinoma. Cui Y; Zhang C; Li Y; Ma S; Cao W; Guan F Cell Biol Int; 2021 Jun; 45(6):1246-1259. PubMed ID: 33559901 [TBL] [Abstract][Full Text] [Related]
29. Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance. Cheng S; Zhou Z; Liu J; Li J; Wang Y; Xiao J; Luo Y Aging (Albany NY); 2024 Jun; 16(11):10016-10032. PubMed ID: 38862257 [TBL] [Abstract][Full Text] [Related]
30. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
31. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma. Posa I; Carvalho S; Tavares J; Grosso AR Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943 [TBL] [Abstract][Full Text] [Related]
32. Expression pattern of Runt-related transcription factor (RUNX) family members and the role of RUNX1 during kidney development. Yano-Sakamoto K; Kitai Y; Toriu N; Yamamoto S; Mizuta K; Saitou M; Tsukiyama T; Taniuchi I; Osato M; Yanagita M Biochem Biophys Res Commun; 2024 Aug; 722():150155. PubMed ID: 38795454 [TBL] [Abstract][Full Text] [Related]
33. Expression of BAG1 is associated with prognosis in kidney renal clear cell carcinoma based on bioinformatics. Wu H; Liu M; He Y; Meng G; Guo W; Guo Q BMC Cancer; 2021 Feb; 21(1):160. PubMed ID: 33581726 [TBL] [Abstract][Full Text] [Related]
34. Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia. Zhao Y; Zhang T; Zhao Y; Zhou J Cancer Biomark; 2020; 29(3):387-397. PubMed ID: 32741803 [TBL] [Abstract][Full Text] [Related]
35. Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration. Zeng Z; Zhang Z; Cheng X; Yang H; Gong B; Zhou X; Zhang C; Wang X; Wang G Cell Signal; 2023 Sep; 109():110743. PubMed ID: 37269962 [TBL] [Abstract][Full Text] [Related]
36. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related]
37. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530 [TBL] [Abstract][Full Text] [Related]
38. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis. Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022 [TBL] [Abstract][Full Text] [Related]
39. OSkirc: a web tool for identifying prognostic biomarkers in kidney renal clear cell carcinoma. Xie L; Wang Q; Dang Y; Ge L; Sun X; Li N; Han Y; Yan Z; Zhang L; Li Y; Zhang H; Guo X Future Oncol; 2019 Sep; 15(27):3103-3110. PubMed ID: 31368353 [No Abstract] [Full Text] [Related]
40. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma. Yang X; Mei C; Nie H; Zhou J; Ou C; He X Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]